577 related articles for article (PubMed ID: 23421098)
41. Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain.
Iskedjian M; Bereza B; Gordon A; Piwko C; Einarson TR
Curr Med Res Opin; 2007 Jan; 23(1):17-24. PubMed ID: 17257464
[TBL] [Abstract][Full Text] [Related]
42. Evaluation of the tolerability and efficacy of Sativex in multiple sclerosis.
Moreno Torres I; Sanchez AJ; Garcia-Merino A
Expert Rev Neurother; 2014 Nov; 14(11):1243-50. PubMed ID: 25331416
[TBL] [Abstract][Full Text] [Related]
43. The role of cannabinoids in regulation of nausea and vomiting, and visceral pain.
Malik Z; Baik D; Schey R
Curr Gastroenterol Rep; 2015 Feb; 17(2):429. PubMed ID: 25715910
[TBL] [Abstract][Full Text] [Related]
44. Medical marijuana patient counseling points for health care professionals based on trends in the medical uses, efficacy, and adverse effects of cannabis-based pharmaceutical drugs.
Parmar JR; Forrest BD; Freeman RA
Res Social Adm Pharm; 2016; 12(4):638-54. PubMed ID: 26443472
[TBL] [Abstract][Full Text] [Related]
45. Dark Classics in Chemical Neuroscience: Δ
Banister SD; Arnold JC; Connor M; Glass M; McGregor IS
ACS Chem Neurosci; 2019 May; 10(5):2160-2175. PubMed ID: 30689342
[TBL] [Abstract][Full Text] [Related]
46. Plant, synthetic, and endogenous cannabinoids in medicine.
Di Marzo V; Petrocellis LD
Annu Rev Med; 2006; 57():553-74. PubMed ID: 16409166
[TBL] [Abstract][Full Text] [Related]
47. Cannabinoids: novel medicines for the treatment of Huntington's disease.
Sagredo O; Pazos MR; Valdeolivas S; Fernandez-Ruiz J
Recent Pat CNS Drug Discov; 2012 Apr; 7(1):41-8. PubMed ID: 22280340
[TBL] [Abstract][Full Text] [Related]
48. Clinical experiences with cannabinoids in spasticity management in multiple sclerosis.
Lorente Fernández L; Monte Boquet E; Pérez-Miralles F; Gil Gómez I; Escutia Roig M; Boscá Blasco I; Poveda Andrés JL; Casanova-Estruch B
Neurologia; 2014 Jun; 29(5):257-60. PubMed ID: 24035293
[TBL] [Abstract][Full Text] [Related]
49. [Cannabinoids in the control of pain].
Shaladi AM; Crestani F; Tartari S; Piva B
Recenti Prog Med; 2008 Dec; 99(12):616-24. PubMed ID: 19388223
[TBL] [Abstract][Full Text] [Related]
50. Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial.
Zajicek J; Fox P; Sanders H; Wright D; Vickery J; Nunn A; Thompson A;
Lancet; 2003 Nov; 362(9395):1517-26. PubMed ID: 14615106
[TBL] [Abstract][Full Text] [Related]
51. Clinical efficacy and effectiveness of Sativex, a combined cannabinoid medicine, in multiple sclerosis-related spasticity.
Oreja-Guevara C
Expert Rev Neurother; 2012 Apr; 12(4 Suppl):3-8. PubMed ID: 22509985
[TBL] [Abstract][Full Text] [Related]
52. Cannabinoids: Therapeutic Use in Clinical Practice.
Pagano C; Navarra G; Coppola L; Avilia G; Bifulco M; Laezza C
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328765
[TBL] [Abstract][Full Text] [Related]
53. [Perspectives of cannabinoids in gastroenterology].
Storr M; Yüce B; Göke B
Z Gastroenterol; 2006 Feb; 44(2):185-91. PubMed ID: 16456761
[TBL] [Abstract][Full Text] [Related]
54. Therapeutic potential of cannabinoid medicines.
Robson PJ
Drug Test Anal; 2014; 6(1-2):24-30. PubMed ID: 24006213
[TBL] [Abstract][Full Text] [Related]
55. Therapeutic potential of cannabinoid-based drugs.
Klein TW; Newton CA
Adv Exp Med Biol; 2007; 601():395-413. PubMed ID: 17713029
[TBL] [Abstract][Full Text] [Related]
56. [Treatment of spasticity in multiple sclerosis: new perspectives regarding the use of cannabinoids].
Oreja-Guevara C
Rev Neurol; 2012 Oct; 55(7):421-30. PubMed ID: 23011861
[TBL] [Abstract][Full Text] [Related]
57. Cancer cachexia and cannabinoids.
Gorter RW
Forsch Komplementarmed; 1999 Oct; 6 Suppl 3():21-2. PubMed ID: 10575285
[TBL] [Abstract][Full Text] [Related]
58. Safety, tolerability, and efficacy of orally administered cannabinoids in MS.
Killestein J; Hoogervorst EL; Reif M; Kalkers NF; Van Loenen AC; Staats PG; Gorter RW; Uitdehaag BM; Polman CH
Neurology; 2002 May; 58(9):1404-7. PubMed ID: 12011290
[TBL] [Abstract][Full Text] [Related]
59. Marijuana: modern medical chimaera.
Lamarine RJ
J Drug Educ; 2012; 42(1):1-11. PubMed ID: 22873011
[TBL] [Abstract][Full Text] [Related]
60. The anti-inflammatory and analgesic effects of formulated full-spectrum cannabis extract in the treatment of neuropathic pain associated with multiple sclerosis.
Maayah ZH; Takahara S; Ferdaoussi M; Dyck JRB
Inflamm Res; 2020 Jun; 69(6):549-558. PubMed ID: 32239248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
